REG-Acquisition of Own Shares
Lakefront Biotherapeutics repurchased 108,679 of its own shares between September 14 and 18, 2026 under the buyback program announced June 9, 2026. The purchases totaled €2,608,832.08 at an average price of €24.00, executed via a discretionary mandate to an independent financial intermediary across Euronext venues.
Key figures
- Average price eur
- 24
- Repurchase period
- September 14-18, 2026
- Total shares held
- 1527534
- Shares repurchased
- 108679
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.